'Sunitinib withdrawal phenomenon' or spontaneous regression in renal cell cancer

Annals of Oncology

Volumn 20, Issue 6, 2009, Pages 1144-1146

  Rothermundt, Christian A ^a   Omlin, A ^a   Gillessen, S ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; SUNITINIB;

ADRENAL METASTASIS; ADULT; ARTICLE; BONE METASTASIS; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CAVA VEIN; CLEAR CELL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY VEIN; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 66149122245     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp239     Document Type: Article

References (8)

1. Bumpus HC. The apparent disappearance of pulmonary metastasis in a case of hypernephroma following nephrectomy. J Urol 1928; 20: 185-191.
2. Lekanidi K, Vlachou PA, Morgan B et al. Spontaneous regression of metastatic renal cell carcinoma: Case report. J Med Case Reports 2007; 1: 89.
3. MacManus MP, Harte RJ, Stranex S. Spontaneous regression of metastatic renal cell carcinoma following palliative irradiation of the primary tumor. Ir J Med Sci 1994; 163: 461-463.
4. Sánchez-Ortiz RF, Tannir N, Ahrar K et al. Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of the primary tumor: An in situ tumor vaccine? J Urol 2003; 170: 178-179.
5. Lokich J. Spontaneous regression of metastatic renal cancer. Case report and literature review. Am J Clin Oncol 1997; 20: 416-418.
6. Mancuso MR, Davis R, Norberg SM et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 2006; 116: 2610-2621.
7. Tobelem G. VEGF: A key therapeutic target for the treatment of cancer - insights into its role and pharmacological inhibition. Targeted Oncology 2007; 2: 153-164.
8. Zhao XY, Malloy PJ, Krishnan AV et al. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 2000; 6: 703-706.